206A Charles Wethington Building, University of Kentucky, 900 South Limestone Street, Lexington, KY 40536, United States. Electronic address: https://twitter.com/JohannaMHoch.
Room A10, Indiana State University, 567 N 5th Street, Terre Haute, IN 47809, United States.
Phys Ther Sport. 2018 Jul;32:269-272. doi: 10.1016/j.ptsp.2018.04.004. Epub 2018 Apr 9.
To determine the test-retest reliability, minimal detectable change (MDC) and responsiveness of the Quick-FAAM in people with chronic ankle instability (CAI).
10-week controlled laboratory study.
Laboratory.
A total of 20 adults with self-reported CAI.
Participants completed a supervised 4-week intervention. The Quick-FAAM was assessed 4-weeks before the intervention (T1), prior to the first intervention (T2), 24-h post-intervention (T3), and 2-weeks after the intervention (T4). The Quick-FAAM is a 12-item region specific PRO scored on 5-point Likert scale, often reported as a percentage, and a lower percentage indicates decreased ankle function. Test-retest reliability was determined using Intraclass-correlation coefficients (ICC) and standard error of measure (SEM). The MDC was calculated using the equation: SEM*√2. Hedges g effect sizes and associated 95% confidence intervals (95%CI) were calculated as a measure of group responsiveness.
The test-retest reliability was clinically acceptable (ICC = 0.82, SEM = 4.56). The MDC was 6.5% and pre-post intervention effect sizes were large between T2-T3 (ES = 1.27, 95%CI:0.59-1.95) and T2-T4 (ES = 1.49, 95%CI:0.79-2.19).
The Quick-FAAM demonstrated clinically acceptable reliability and was responsive to treatment. Future research should examine these properties in patients with acute ankle and foot conditions, determine patient acceptability, and clinician feasibility.
确定慢性踝关节不稳（CAI）患者 Quick-FAAM 的重测信度、最小可检测变化（MDC）和反应度。
10 周对照实验室研究。
实验室。
共 20 名有慢性踝关节不稳（CAI）自述的成年人。
参与者完成了为期 4 周的监督干预。Quick-FAAM 在干预前 4 周（T1）、第一次干预前（T2）、干预后 24 小时（T3）和干预后 2 周（T4）进行评估。Quick-FAAM 是一种 12 项区域特定的 PRO，用 5 分李克特量表评分，通常报告为百分比，百分比越低表示踝关节功能下降。重测信度采用组内相关系数（ICC）和测量标准误差（SEM）确定。MDC 用方程计算：SEM*√2。Hedges g 效应大小及其相关 95%置信区间（95%CI）作为组反应性的衡量标准。
重测信度具有临床可接受性（ICC=0.82，SEM=4.56）。MDC 为 6.5%，T2-T3（ES=1.27，95%CI：0.59-1.95）和 T2-T4（ES=1.49，95%CI：0.79-2.19）之间的干预前后效应大小较大。
Quick-FAAM 具有临床可接受的可靠性，对治疗有反应。未来的研究应该在急性踝关节和足部疾病患者中检验这些特性，确定患者的可接受性和临床医生的可行性。
